1upHealth operates a healthcare data platform for patients, providers, and software developers to aggregate and share medical data. 1upHealth is a way for healthcare organizations to connect, control and compute on your data. The company's platform monitors patient activity and automates secure data sharing from patients' electronic medical records and wearable device metrics within a trusted interoperability network, allowing patients to share data from disparate sources and improve healthcare outcomes.
Aera Therapeutics is a biotechnology company that uses its proprietary protein nanoparticle (PNP) delivery platform to help genetic medicines reach their full potential. Aera's platform, which is based on endogenous human proteins, is being developed to address the limitations of current delivery technologies and to extend the reach of genetic medicines to different tissues and applications, thereby benefiting more patients across a broader range of disease areas. In addition, Aera's licensed technology includes a therapeutic enzyme platform based on the discovery of novel, compact, and programmable gene-editing enzymes.
Affinia Therapeutics is a developer of a platform for rationally designed adeno-associated virus (AAV) vectors and gene therapies intended to develop medicines for devastating diseases. The company leverages synthetic and systems biology combined with high-throughput screening and tissue and single-cell resolution for people affected by muscle and central nervous system (CNS) diseases with significant unmet needs, thereby providing medical professionals with the rational design of novel vectors and gene therapies with remarkably improved properties.
1000’s of scientists, technicians, and engineers across 30+ countries rely on Albert’s end-to-end Cloud Platform to accelerate the innovation of new materials. With Albert, R&D organizations get the data insights and tools needed to increase speed to market, automate regulatory compliance, and heighten the impact of new products. Built from the ground up for the chemical and material science industry, the Albert Platform connects R&D processes and creates a single data source of truth across the R&D organization. Augmented with AI, machine learning and a comprehensive materials database, key platform functionality includes inventory, worksheets, workflows, tasks, and more. www.albertinvent.com
Amber Therapeutics develops the next-generation of bioelectrical therapies that can sense and adapt as well as stimulate, with the potential to radically improve clinical outcomes in patients with functional disorders of the peripheral nervous system.
AmplifyMD is a telemedicine platform connecting over 3,300 medical institutions with a lack of specialty access, often in rural or small regions to a network of leading specialists.AmplifyMD provides both the clinical team as well as the software to streamline and automate virtual care delivery and billing workflows and integrates seamlessly with hospitals' existing EHRs.
